Professor David Sebag-Montefiore outlines the profound impact of radiotherapy research. Through global trials and personalised approaches, innovation advances cancer care. Collaborative efforts ensure patient-centred treatments, paving the way for smarter, kinder therapies and a future of precision oncology.
The Long COVID lessons learned beyond the COVID-19 pandemic are detailed here by leading Professors working on the University College London STIMULATE-ICP programme.
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
Remote healthcare communication tools can be highly effective and useful for collaboration, clinical assessments, and surgical training, finds Ingo Aicher, Managing Director at Jones AV Limited.
A Phase 1 clinical trial of a universal flu vaccine has started inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Maryland.
Both alcoholic and non-alcoholic lager beer drank in moderation can improve gut microbes in men – lessening the chances of developing chronic diseases.
The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Richard Armstrong, head of registries at NEC Software Solutions UK, puts real-world evidence under the microscope and examines how, as our population ages it has the power to speed up medical interventions at scale.
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
